The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic inflammatory sinus ...
The U.S. Food and Drug Administration has approved Amgen and AstraZeneca's drug for a type of chronic sinus infection, the ...
The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
The 2025 U.S. Asthma Capitals report identifies cities with high rates of asthma-related emergency room visits and deaths.
The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.
Asthma remains a significant health burden in the U.S., with more than 60% of adults continuing to experience frequent symptoms despite the ...
President Donald Trump recently postponed a planned 100% tariff on imported pharmaceuticals just as Pfizer rolled out a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback